IP Library Granted Patent US 12,274,871
Granted Patent B1
US 12,274,871 · App. 18/619,996 · Granted Apr 15, 2025

Hold detent mechanism for injection devices

Inventors: Alexander Hee-Hanson (Melbourn, GB); Thomas Lever (Melbourn, GB); Michael Parrott (Melbourn, GB); Robert Wilson (Melbourn, GB)
Assignee: Genzyme Corporation
A61M5/322
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,274,871
App. No.
18/619,996
Granted
Apr 15, 2025
Kind
B1
Abstract

Some injection devices include an injection device body, a needle shroud retractable into the injection device body, a control spring coupled to the needle shroud and biased to cause the needle shroud to be at least partially extended from the injection device body in an initial position, and a hold detent mechanism coupled to at least the needle shroud. The hold detent mechanism is configured to (i) activate, when the needle shroud is retracted from the initial position into the injection device body to a hold position, to create a hold detent force, and (ii) deactivate, when the needle shroud is extracted from the hold position subsequent to the retraction, to release the hold detent force and enable the needle shroud to extend from the injection device body to substantially the initial position.

Claims (78)

1. An injection device comprising:

an injection device body;

a needle shroud retractable into the injection device body;

a control spring coupled to the needle shroud and biased to cause the needle shroud to be at least partially extended from the injection device body in an initial position; and

a hold detent mechanism coupled to at least the needle shroud, wherein the hold detent mechanism is configured to:

activate, when the needle shroud is retracted from the initial position into the injection device body to a hold position, to create a hold detent force opposite a control spring force caused by compression of the control spring during said retraction of needle shroud to said hold position; and

deactivate, when the needle shroud is extracted from the hold position subsequent to the retraction, to release the hold detent force and enable the needle shroud to extend from the injection device body to substantially the initial position; and

a collar within the injection device body and rotatably configured for guiding said needle shroud between the initial position and the hold position;

a plunger and biasing means for biasing the plunger towards a distal end of the injection device,

wherein when the needle shroud is in the initial position, the plunger is retained by a combination of a rear casing of the injection device and the collar preventing the biasing means from displacing the plunger in a distal direction, and on activation of the injection device, the collar rotates and guides the needle shroud to the holding position and causing, when the needle shroud is in the holding position, the biasing means to move the plunger in the distal direction of the injection device.

2. The injection device of claim 1 , wherein the hold detent mechanism comprises a first hold detent feature coupled to the needle shroud, which, when activated, interacts with a second hold detent feature on the injection device body for creating the hold detent force.

3. The injection device of claim 1 , wherein the hold detent mechanism comprises a first hold detent feature coupled to the needle shroud, which, when activated, interacts with a second hold detent feature on the collar for creating the hold detent force.

4. The injection device of claim 2 , wherein the first hold detent feature comprises at least one of:

a flexible arm;

a resilient clip;

a high friction interface; or

partial cut-out or flap on the needle shroud.

5. The injection device of claim 2 , wherein the first hold detent feature comprises a male feature, and the second hold detent feature comprises at least one of:

a recess for mating with said male feature of the first hold detent feature;

a partial recess for mating with said male feature of the first hold detent feature;

a male feature configured to interact and couple with the male feature of the first hold detent feature; or

a high friction interface.

6. The injection device of claim 5 , wherein;

the male feature of the first hold detent feature comprises at least one ramped contact face configured for flexing a portion of the first hold detent feature radially away from the injection device body or the collar when the needle shroud is in the initial position and/or prior retracting to the hold position;

when the needle shroud is retracted to the hold position, the hold detent mechanism activates by the at least one ramped contact face of the male feature of the first hold detent feature interacting with the second hold detent feature of the injection device body or the collar causing the portion of the first hold detent feature to radially flex towards the injection device body or the collar, respectively, and create the hold detent force opposite the control spring force; and

when the needle shroud is extracted from the hold position subsequent to the retraction, the hold detent mechanism is deactivated by the at least one ramped contact face of the male feature of the first hold detent feature interacting with the second hold detent feature to radially flex the portion of the first hold detent feature away from the injection device body or the collar, respectively, enabling the control spring force to extract the needle shroud to substantially the initial position.

7. The injection device of claim 2 , wherein the first hold detent feature is coupled to the needle shroud by a snap fit.

8. The injection device of claim 2 , wherein the first hold detent feature is integral to the needle shroud and formed by a resilient partial cut-out of the needle shroud.

9. The injection device of claim 1 , wherein the hold detent force of the hold detent mechanism at least partially supports the needle shroud against the control spring force rather than an entirety of the control spring force being fully transferred to a user when the injection device is in the hold position.

10. The injection device of claim 1 , wherein the control spring is a compression spring configured to bias the needle shroud towards an extended position.

11. The injection device of claim 1 , wherein the injection device further comprises a needle, and wherein the needle shroud is arranged to shroud the needle when in an extended position.

12. The injection device of claim 11 , wherein the injection device further comprises a reservoir containing a medicament, the reservoir coupled to the plunger via a stopper at a distal portion of the reservoir and the reservoir coupled to the needle at a proximal end of the reservoir, and wherein, when the needle shroud moves into the hold position, the biasing means moves the plunger to displace the stopper in the distal direction causing the medicament stored in the reservoir to be expelled from the injection device via the needle.

13. The injection device of claim 1 , further comprising at least two hold detent mechanisms equally spaced around a circumference of the needle shroud.

14. A hold detent mechanism for an injection device, the hold detent mechanism comprising:

a first hold detent feature coupled to a needle shroud, wherein the needle shroud is retractable into an injection device body and coupled to a control spring, the control spring biased to cause the needle shroud to be at least partially extended from the injection device body in an initial position, the first hold detent feature comprising a male feature;

a second hold detent feature comprises at least one of (i) a recess for mating with said male feature of the first hold detent feature, (ii) a partial recess for mating with said male feature of the first hold detent feature, (iii) a male feature configured to interact and couple with the male feature of the first hold detent feature, or (iv) a high friction interface,

wherein the hold detent mechanism is configured to:

activate the first hold detent feature, when the needle shroud is retracted from the initial position into the injection device body to a hold position, to create a hold detent force opposite a control spring force caused by compression of the control spring during said retraction of needle shroud to said hold position; and

deactivate the first hold detent feature, when the needle shroud is extracted from the hold position subsequent to the retraction, to release the hold detent force and enable the needle shroud to extend from the injection device body to substantially the initial position,

wherein the male feature of the first hold detent feature comprises at least one ramped contact face configured for flexing a portion of the first hold detent feature radially away from the injection device body when the needle shroud is in the initial position and/or prior retracting to the hold position,

wherein when the needle shroud is retracted to the hold position, the first hold detent feature of the hold detent mechanism activates by the at least one ramped contact face of the male feature of the first hold detent feature interacting with the second hold detent feature of the injection device body causing the portion of the first hold detent feature to radially flex towards the injection device body and create the hold detent force opposite the control spring force, and

wherein when the needle shroud is extracted from the hold position subsequent to the retraction, the first hold detent feature of the hold detent mechanism is deactivated by the at least one ramped contact face of the male feature of the first hold detent feature interacting with the second hold detent feature to radially flex the portion of the first hold detent feature away from the injection device body enabling the control spring force to extract the needle shroud to substantially the initial position.

15. The hold detent mechanism of claim 14 , wherein the second hold detent feature is on the injection device body.

16. The hold detent mechanism of claim 14 , wherein the injection device further comprises a collar within the injection device body and configured for guiding said needle shroud between the initial position and the hold position.

17. The hold detent mechanism of claim 14 , wherein the first hold detent feature comprises at least one of:

a flexible arm;

a resilient clip;

a high friction interface; or

partial cut-out or flap on the needle shroud.

18. The hold detent mechanism of claim 14 , wherein the first hold detent feature is coupled to the needle shroud by a snap fit.

19. The hold detent mechanism of claim 14 , wherein the first hold detent feature is integral to the needle shroud and formed by a resilient partial cut-out of the needle shroud.

20. The hold detent mechanism of claim 14 , wherein the hold detent force of the hold detent mechanism at least partially supports the needle shroud against the control spring force rather than an entirety of the control spring force being fully transferred to a user when the injection device is in the hold position.

21. The hold detent mechanism of claim 14 , wherein the control spring is a compression spring configured to bias the needle shroud towards an extended position.

22. The hold detent mechanism of claim 14 , wherein the first hold detent feature comprises at least one of a flexible arm, a resilient clip, a high friction interface, or partial cut-out or flap.

23. A hold detent mechanism for an injection device, the hold detent mechanism comprising:

a first hold detent feature coupled to a needle shroud, wherein the needle shroud is retractable into an injection device body and coupled to a control spring, the control spring biased to cause the needle shroud to be at least partially extended from the injection device body in an initial position, the first hold detent feature comprising a male feature;

wherein the hold detent mechanism is configured to:

activate the first hold detent feature, when the needle shroud is retracted from the initial position into the injection device body to a hold position, to create a hold detent force opposite a control spring force caused by compression of the control spring during said retraction of needle shroud to said hold position; and

deactivate the first hold detent feature, when the needle shroud is extracted from the hold position subsequent to the retraction, to release the hold detent force and enable the needle shroud to extend from the injection device body to substantially the initial position; and

a collar within the injection device body and configured for guiding said needle shroud between the initial position and the hold position, wherein the first hold detent feature, which, when activated, interacts with a second hold detent feature on the collar for creating the hold detent force, the second hold detent feature comprising at least one of (i) a recess for mating with said male feature of the first hold detent feature, (ii) a partial recess for mating with said male feature of the first hold detent feature, (iii) a male feature configured to interact and couple with the male feature of the first hold detent feature, or (iv) a high friction interface,

wherein the male feature of the first hold detent feature comprises at least one ramped contact face configured for flexing a portion of the first hold detent feature radially away from the collar when the needle shroud is in the initial position and/or prior retracting to the hold position,

wherein when the needle shroud is retracted to the hold position, the first hold detent feature of the hold detent mechanism activates by the at least one ramped contact face of the male feature of the first hold detent feature interacting with the second hold detent feature of the collar causing the portion of the first hold detent feature to radially flex towards the collar, and create the hold detent force opposite the control spring force, and

wherein when the needle shroud is extracted from the hold position subsequent to the retraction, the first hold detent feature of the hold detent mechanism is deactivated by the at least one ramped contact face of the male feature of the first hold detent feature interacting with the second hold detent feature to radially flex the portion of the first hold detent feature away from the collar enabling the control spring force to extract the needle shroud to substantially the initial position.

24. The hold detent mechanism of claim 23 , wherein the first hold detent feature is coupled to the needle shroud by a snap fit.

25. The hold detent mechanism of claim 23 , wherein the first hold detent feature is integral to the needle shroud and formed by a resilient partial cut-out of the needle shroud.

26. The hold detent mechanism of claim 23 , wherein the hold detent force of the hold detent mechanism at least partially supports the needle shroud against the control spring force rather than an entirety of the control spring force being fully transferred to a user when the injection device is in the hold position.

27. An injection device comprising:

an injection device body;

a needle shroud retractable into the injection device body;

a control spring coupled to the needle shroud and biased to cause the needle shroud to be at least partially extended from the injection device body in an initial position; and

a hold detent mechanism coupled to at least the needle shroud, wherein the hold detent mechanism is configured to:

activate, when the needle shroud is retracted from the initial position into the injection device body to a hold position, to create a hold detent force opposite a control spring force caused by compression of the control spring during said retraction of needle shroud to said hold position; and

deactivate, when the needle shroud is extracted from the hold position subsequent to the retraction, to release the hold detent force and enable the needle shroud to extend from the injection device body to substantially the initial position,

wherein the hold detent mechanism comprises a first hold detent feature coupled to the needle shroud, which, when activated, interacts with a second hold detent feature on the injection device body for creating the hold detent force,

wherein the first hold detent feature comprises a male feature, and the second hold detent feature comprises at least one of (i) a recess for mating with said male feature of the first hold detent feature, (ii) a partial recess for mating with said male feature of the first hold detent feature, (iii) a male feature configured to interact and couple with the male feature of the first hold detent feature, or (iv) a high friction interface,

wherein the male feature of the first hold detent feature comprises at least one ramped contact face configured for flexing a portion of the first hold detent feature radially away from the injection device body or a collar when the needle shroud is in the initial position and/or prior retracting to the hold position,

when the needle shroud is retracted to the hold position, the hold detent mechanism activates by the at least one ramped contact face of the male feature of the first hold detent feature interacting with the second hold detent feature of the injection device body or the collar causing the portion of the first hold detent feature to radially flex towards the injection device body or the collar, respectively, and create the hold detent force opposite the control spring force, and

when the needle shroud is extracted from the hold position subsequent to the retraction, the hold detent mechanism is deactivated by the at least one ramped contact face of the male feature of the first hold detent feature interacting with the second hold detent feature to radially flex the portion of the first hold detent feature away from the injection device body or the collar, respectively, enabling the control spring force to extract the needle shroud to substantially the initial position.

Assignments (8)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2025
From: SANOFI-AVENTIS DEUTSCHLAND GMBH
To: GENZYME CORPORATION
Reel/Frame 070317/0378 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2025
From: HEE-HANSON, ALEXANDER; LEVER, THOMAS; PARROTT, MICHAEL; WILSON, ROBERT
To: PA HOLDINGS LIMITED
Reel/Frame 070317/0107 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2025
From: PA HOLDINGS LIMITED
To: PA CONSULTING SERVICES LIMITED
Reel/Frame 070317/0264 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2025
From: PA CONSULTING SERVICES LIMITED
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 070317/0343 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2025
From: HEE-HANSON, ALEXANDER; LEVER, THOMAS; PARROTT, MICHAEL; WILSON, ROBERT
To: PA HOLDINGS LIMITED
Reel/Frame 070286/0061 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2025
From: PA HOLDINGS LIMITED
To: PA CONSULTING SERVICES LIMITED
Reel/Frame 070286/0180 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2025
From: PA CONSULTING SERVICES
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 070286/0310 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2025
From: SANOFI-AVENTIS DEUTSCHLAND GMBH
To: GENZYME CORPORATION
Reel/Frame 070286/0416 →
References Cited (47)
US 4900311A · Stern et al. · 1990 [cited by applicant]
US 5088986A · Nusbaum · 1992 [cited by applicant]
US 5290256A · Weatherford et al. · 1994 [cited by applicant]
US 5688241A · Asbaghi · 1997 [cited by examiner]
US 7597685B2 · Olson · 2009 [cited by applicant]
US 8016797B2 · Gratwohl et al. · 2011 [cited by applicant]
US 8821451B2 · Daniel · 2014 [cited by applicant]
US 9199038B2 · Daniel · 2015 [cited by applicant]
US 9408976B2 · Olson et al. · 2016 [cited by applicant]
US 9498579B2 · Ruan · 2016 [cited by applicant]
US 9662452B2 · Daniel · 2017 [cited by applicant]
US 9867940B2 · Holmqvist et al. · 2018 [cited by applicant]
US 9919107B2 · Imai · 2018 [cited by examiner]
US 10420898B2 · Daniel · 2019 [cited by applicant]
US 11369751B2 · Ruan · 2022 [cited by examiner]
US 11944787B2 · Franke · 2024 [cited by applicant]
US 20060276756A1 · Francavilla · 2006 [cited by applicant]
US 20100268170A1 · Carrel et al. · 2010 [cited by applicant]
US 20120203186A1 · Vogt et al. · 2012 [cited by applicant]
US 20130041328A1 · Daniel · 2013 [cited by applicant]
US 20130096512A1 · Ekan et al. · 2013 [cited by applicant]
US 20130123710A1 · Ekman et al. · 2013 [cited by applicant]
US 20130261559A1 · Werbickas · 2013 [cited by applicant]
US 20140025013A1 · Dowds et al. · 2014 [cited by applicant]
US 20150190580A1 · Imai et al. · 2015 [cited by applicant]
US 20150258283A1 · Imai et al. · 2015 [cited by applicant]
US 20160089498A1 · Daniel · 2016 [cited by applicant]
US 20180064875A1 · Holmqvist · 2018 [cited by applicant]
US 20180361082A1 · Sall et al. · 2018 [cited by applicant]
US 20200289755A1 · Franke · 2020 [cited by applicant]
US 20210236732A1 · Chu et al. · 2021 [cited by applicant]
US 20210244887A1 · Halseth · 2021 [cited by applicant]
US 20210393886A1 · Nicolas et al. · 2021 [cited by applicant]
US 20220387719A1 · Wang et al. · 2022 [cited by applicant]
US 20220395642A1 · Karlsson · 2022 [cited by applicant]
US 20240139430A1 · Chansavang et al. · 2024 [cited by applicant]
US 20240165346A1 · Chansavang et al. · 2024 [cited by applicant]
WO WO2011123024 · 2011 [cited by applicant]
WO WO2014115241A1 · 2014 [cited by applicant]
WO WO2021008839 · 2021 [cited by applicant]
WO WO2023104512A1 · 2023 [cited by applicant]
Needle-based injection systems for medical use requirements and test methods, Part 1: Needle injection systems, ISO 11608-1:2014(E), Third Edition, Switzerland, ISO, Dec. 15, 2014, pp. 1-13. [cited by applicant]
U.S. Appl. No. 18/619,754, filed Mar. 28, 2024, Alexander Hee-Hanson. [cited by applicant]
U.S. Appl. No. 18/619,991, filed Mar. 28, 2024, Alexander Hee-Hanson. [cited by applicant]
U.S. Appl. No. 18/620,210, filed Mar. 28, 2024, Alexander Hee-Hanson. [cited by applicant]
U.S. Appl. No. 18/620,586, filed Mar. 28, 2024, Alexander Hee-Hanson. [cited by applicant]
U.S. Appl. No. 18/620,097, filed Mar. 28, 2024, Alexander Hee-Hanson. [cited by applicant]
Cited By (2)
US 12,427,266 US 12,502,482